66 related articles for article (PubMed ID: 21109968)
1. The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells.
Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Del Barco S; Martin-Castillo B; Lopez-Bonet E; Menendez JA
Oncol Rep; 2011 Jan; 25(1):135-40. PubMed ID: 21109968
[TBL] [Abstract][Full Text] [Related]
2. Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer.
Athreya AP; Kalari KR; Cairns J; Gaglio AJ; Wills QF; Niu N; Weinshilboum R; Iyer RK; Wang L
Oncotarget; 2017 Apr; 8(16):27199-27215. PubMed ID: 28423712
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of targeted therapy in combination with metformin on human breast cancer cell lines.
Mahmoudi G; Ehteshaminia Y; Kokhaei P; Jalali SF; Jadidi-Niaragh F; Pagheh AS; Enderami SE; Kenari SA; Hassannia H
Cell Commun Signal; 2024 Jan; 22(1):10. PubMed ID: 38167105
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of metformin in breast cancer: involvement of the immune system?
Schott S; Bierhaus A; Schuetz F; Beckhove P; Schneeweiss A; Sohn C; Domschke C
Cancer Immunol Immunother; 2011 Sep; 60(9):1221-5. PubMed ID: 21681370
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer.
Abdolvand M; Shahini Shams Abadi M; Soltani A; Banisharif F; Ghatrehsamani M
Heliyon; 2023 Nov; 9(11):e21060. PubMed ID: 37964831
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic landscape profiling of metformin-treated healthy mice: Implication for potential hypertension risk when prophylactically used.
Meng Y; Xiang R; Yan H; Zhou Y; Hu Y; Yang J; Zhou Y; Cui Q
J Cell Mol Med; 2020 Jul; 24(14):8138-8150. PubMed ID: 32529766
[TBL] [Abstract][Full Text] [Related]
7. Metformin: From Diabetes to Cancer-Unveiling Molecular Mechanisms and Therapeutic Strategies.
Amengual-Cladera E; Morla-Barcelo PM; Morán-Costoya A; Sastre-Serra J; Pons DG; Valle A; Roca P; Nadal-Serrano M
Biology (Basel); 2024 Apr; 13(5):. PubMed ID: 38785784
[TBL] [Abstract][Full Text] [Related]
8. Metformin and Breast Cancer: Current Findings and Future Perspectives from Preclinical and Clinical Studies.
Corleto KA; Strandmo JL; Giles ED
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543182
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Characterization of Lipophilic Salts of Metformin to Improve Its Repurposing for Cancer Therapy.
Saeed HK; Sutar Y; Patel P; Bhat R; Mallick S; Hatada AE; Koomoa DT; Lange I; Date AA
ACS Omega; 2021 Feb; 6(4):2626-2637. PubMed ID: 33553880
[TBL] [Abstract][Full Text] [Related]
10. Impact of metformin on metastases in patients with breast cancer and type 2 diabetes.
Jacob L; Kostev K; Rathmann W; Kalder M
J Diabetes Complications; 2016 Aug; 30(6):1056-9. PubMed ID: 27130560
[TBL] [Abstract][Full Text] [Related]
11. Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner.
Cerezo M; Tichet M; Abbe P; Ohanna M; Lehraiki A; Rouaud F; Allegra M; Giacchero D; Bahadoran P; Bertolotto C; Tartare-Deckert S; Ballotti R; Rocchi S
Mol Cancer Ther; 2013 Aug; 12(8):1605-15. PubMed ID: 23741061
[TBL] [Abstract][Full Text] [Related]
12. Proteomic Analysis Reveals That Metformin Suppresses PSMD2, STIP1, and CAP1 for Preventing Gastric Cancer AGS Cell Proliferation and Migration.
Wang WH; Chen SK; Huang HC; Juan HF
ACS Omega; 2021 Jun; 6(22):14208-14219. PubMed ID: 34124444
[TBL] [Abstract][Full Text] [Related]
13. Crocin and Metformin suppress metastatic breast cancer progression via VEGF and MMP9 downregulations: in vitro and in vivo studies.
Farahi A; Abedini MR; Javdani H; Arzi L; Chamani E; Farhoudi R; Talebloo N; Hoshyar R
Mol Cell Biochem; 2021 Sep; 476(9):3341-3351. PubMed ID: 33929675
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Metformin on the Clinicopathological Features of Breast Cancer With Type 2 Diabetes.
Min W; Wang B; Guo A; Mao G; Zhao Y; Zhang S; He R; Min Y; Huang Y
World J Oncol; 2020 Feb; 11(1):23-32. PubMed ID: 32095186
[TBL] [Abstract][Full Text] [Related]
15. Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study.
Lee DJ; McMullen CP; Foreman A; Huang SH; Lu L; Xu W; de Almeida JR; Liu G; Bratman SV; Goldstein DP
J Otolaryngol Head Neck Surg; 2019 Jul; 48(1):34. PubMed ID: 31345259
[TBL] [Abstract][Full Text] [Related]
16. The anticancer potential of metformin on prostate cancer.
Zaidi S; Gandhi J; Joshi G; Smith NL; Khan SA
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):351-361. PubMed ID: 30651580
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CD24 suppresses bone metastasis of lung cancer.
Okabe H; Aoki K; Yogosawa S; Saito M; Marumo K; Yoshida K
Cancer Sci; 2018 Jan; 109(1):112-120. PubMed ID: 29095550
[TBL] [Abstract][Full Text] [Related]
18. Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers.
Leung EY; Askarian-Amiri ME; Sarkar D; Ferraro-Peyret C; Joseph WR; Finlay GJ; Baguley BC
Front Oncol; 2017; 7():184. PubMed ID: 28929082
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women.
Hong JL; Jonsson Funk M; Buse JB; Henderson LM; Lund JL; Pate V; Stürmer T
Epidemiology; 2017 May; 28(3):446-454. PubMed ID: 28166101
[TBL] [Abstract][Full Text] [Related]
20. Metformin targets multiple signaling pathways in cancer.
Lei Y; Yi Y; Liu Y; Liu X; Keller ET; Qian CN; Zhang J; Lu Y
Chin J Cancer; 2017 Jan; 36(1):17. PubMed ID: 28126011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
